Theralase Technologies Inc. V.TLT

Numbers & Percentages of Evaluable Patients

[Eoganacht]

May 30, 2022 - Number of Patients
	90 Days	180 Days	270 Days	360 Days	450 Days
CR	17	16	10	5	5
PR	8	7	2	4	2
TR	25	23	12	9	7
NR	12	9	14	14	15
Total Evaluable	37	32	26	23	22
May 30, 2022 - Percentages
	90 Days	180 Days	270 Days	360 Days	450 Days
CR	46%	50%	39%	22%	23%
PR	22%	22%	8%	17%	9%
TR	68%	72%	46%	39%	32%
NR	32%	28%	54%	61%	69%
Total Evaluable	37	32	26	23	22
August 29, 2022 - Number of Patients
	90 Days	180 Days	270 Days	360 Days	450 Days
CR	19	16	13	9	5
PR	6	9	7	3	3
TR	25	25	20	12	8
NR	13	9	12	14	16
Total Evaluable	38	34	32	26	24
August 29, 2022 -Percentages
	90 Days	180 Days	270 Days	360 Days	450 Days
CR	50%	47%	41%	35%	21%
PR	16%	26%	22%	12%	13%
TR	66%	74%	63%	46%	33%
NR	34%	26%	37%	54%	67%
Total Evaluable	38	34	32	26	24

 

[CancerSlayer]

  Thanks for clearly stating those raw numbers Eoganacht... A further breakdown for the current 24 evaluable patients at 450 days (plus the two pending 450 day patients):   KEY: CR+2 = the two pending 450 day patients convert to CRs PR-C = PR converts to CR All CR = All pending & PR patients convert to CR No-C = None convert to CR           &

[Legit62]

Looking at these numbers looks great compared to competitors plus almost no side affects, if the data keeps up this trend we are BtD by end of year!! Great post Eoganacht and SF, numbers matter at this point in time not employees

[CancerSlayer]

Correction highlighted below....

[riverrrow]

So does this mean that there was a 90 day period during which only 1 patient was treated?  Is this why there's no buying intetest in spite of the good results?

[Rumpl3StiltSkin]

I think most investors/traders and analysts take the Summer off. This last NR would have been under their radar anyway, as it was just a routine financial... So, yes only 1 treated in that period, yet there are 4 more out there due to get to 90day at some point... More improvement in the numbers moving through, IMO.

[enriquesuave]

Excellent summary and comparison.  When we look at these numbers, we must remember that they include the 1set of 12 undertreated where 5 were dropped without a 2nd optimized treatment and 1 patient who died of unrelated cause.  So at 360 days the 9 CR out of 26 could really be 9 out of 20 with 3 out of 20 PR.  Numbers are getting better quite significantly, it this keeps up we can

[Rumpl3StiltSkin]

Also 1 of these 45 patients was from Phase 1, who failed for some reason?? I can't remember.

[CancerSlayer]

Agree....And kudos to our ACT if we are granted a BTD based on data that derives from a significant % of undertreated patients...this would be further testament to the potency & potential of our ACT.   However, the grant of an AA & the publication of trial results are at a whole different level.  Such a milestone achievement (AA) & its publication should ultimately be based